Cargando…

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays

Laboratories now can choose from >100 human papillomavirus (HPV) assays for cervical screening. Our previous analysis based on the data from the Danish Horizon study, however, showed that four widely used assays, Hybrid Capture 2 (HC2), cobas, CLART, and Aptima, frequently do not detect the same...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rebolj, Matejka, Bonde, Jesper, Preisler, Sarah, Ejegod, Ditte, Rygaard, Carsten, Lynge, Elsebeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2016
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078541/ https://www.ncbi.nlm.nih.gov/pubmed/27535689 http://dx.doi.org/10.1128/JCM.01321-16

Ejemplares similares

Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
por: Rebolj, Matejka, et al.
Publicado: (2016)

Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening
por: Rebolj, Matejka, et al.
Publicado: (2014)

HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system
por: Bonde, Jesper, et al.
Publicado: (2014)

Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study
por: Preisler, Sarah, et al.
Publicado: (2016)

Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay
por: Preisler, Sarah, et al.
Publicado: (2013)

Human papillomavirus self‐sampling for screening nonattenders: Opt‐in pilot implementation with electronic communication platforms
por: Lam, Janni Uyen Hoa, et al.
Publicado: (2017)

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders
por: Lam, J U H, et al.
Publicado: (2018)

Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study
por: Ejegod, Ditte Møller, et al.
Publicado: (2015)

Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders
por: Lam, J. U. H., et al.
Publicado: (2017)

Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review
por: Rebolj, Matejka, et al.
Publicado: (2011)

Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark
por: Rebolj, Matejka, et al.
Publicado: (2015)

Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework
por: Bonde, Jesper Hansen, et al.
Publicado: (2020)

Role of human papillomavirus status after conization for high‐grade cervical intraepithelial neoplasia
por: Huang, Huei‐Jean, et al.
Publicado: (2020)

Condom use to enhance regression of cervical intraepithelial neoplasia: study protocol for a randomized controlled trial
por: Skorstengaard, Malene, et al.
Publicado: (2019)

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
por: Ejegod, Ditte, et al.
Publicado: (2016)

Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia
por: Lehtinen, Matti, et al.
Publicado: (2011)

Effect of human papillomavirus genotype on severity and prognosis of cervical intraepithelial neoplasia
por: Ku, Chun-Hoe, et al.
Publicado: (2014)

Human papillomavirus infection in women who develop high-grade cervical intraepithelial neoplasia or cervical cancer: a case–control study in the UK
por: Grainge, M J, et al.
Publicado: (2005)

Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review
por: Bonde, Jesper, et al.
Publicado: (2020)

Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study
por: Rebolj, Matejka, et al.
Publicado: (2012)

Human Papillomavirus Same Genotype Persistence and Risk of Cervical Intraepithelial Neoplasia2+ Recurrence
por: Iacobone, Anna Daniela, et al.
Publicado: (2021)

Prevalence of high‐risk human papillomavirus after HPV‐vaccination in Denmark
por: Lynge, Elsebeth, et al.
Publicado: (2020)

Human papilloma virus genotyping for the cross‐sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more
por: Del Mistro, Annarosa, et al.
Publicado: (2018)

Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women
por: Muñoz, N, et al.
Publicado: (2009)

Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis
por: Zhang, Junya, et al.
Publicado: (2020)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

The prevalence of human papillomavirus antigen in patients with cervical intraepithelial neoplasia.
por: Walker, P. G., et al.
Publicado: (1983)

Detection of Human Papillomavirus Infection in Patients with Vaginal Intraepithelial Neoplasia
por: Lamos, Cristina, et al.
Publicado: (2016)

The relative risk of noncervical high‐risk human papillomavirus‐related (pre)malignancies after recurrent cervical intraepithelial neoplasia grade 3: A population‐based study
por: Loopik, Diede L., et al.
Publicado: (2019)

A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland
por: Hinkula, M, et al.
Publicado: (2004)

Conization and healthcare use: a population-based register study
por: Frederiksen, Maria E., et al.
Publicado: (2019)

Vulvar intraepithelial neoplasia: Incidence and long‐term risk of vulvar squamous cell carcinoma
por: Thuijs, Nikki B., et al.
Publicado: (2020)

Past cervical intraepithelial neoplasia grade 3, obesity, and earlier menopause are associated with an increased risk of vulval cancer in postmenopausal women
por: Coffey, Kate, et al.
Publicado: (2016)

Incidence of cervical cancer after several negative smear results by age 50: prospective observational study
por: Rebolj, Matejka, et al.
Publicado: (2009)

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?
por: Castañon, Alejandra, et al.
Publicado: (2018)

Genotype-specific methylation of HPV in cervical intraepithelial neoplasia
por: Hsu, Yaw-Wen, et al.
Publicado: (2017)

Epidemiological evidence of cervical intraepithelial neoplasia without the presence of human papillomavirus.
por: Burger, M. P., et al.
Publicado: (1996)

Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology
por: Wall, S R, et al.
Publicado: (2005)

Clinical analysis of cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia
por: He, Yue, et al.
Publicado: (2017)

Genotype distribution of human papillomavirus (HPV) in histological sections of cervical intraepithelial neoplasia and invasive cervical carcinoma in Madrid, Spain
por: García-Espinosa, Benjamín, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qkr8rhtk9d0qeou861qa70m346